Antengene Corporation Ltd.

05/12/2021 | Press release | Distributed by Public on 05/13/2021 02:13

VOLUNTARY ANNOUNCEMENT NMPA APPROVAL OF IND APPLICATION FOR A PHASE III CLINICAL TRIAL OF SELINEXOR IN ADVANCED OR RECURRENT ENDOMETRIAL CANCER